Thus, although the focus of this work was on studying anti-tumour CAR-T cell responses, simultaneous activation of NK cells is also likely given that both CCL5 and IL-15 are key drivers of NK cell recruitment and activation. The gene discussed is IL15; the disease is neoplasm.